Klotho-regulated serine (RELA) phosphorylation can negatively regulate the production of NF-κB-linked inflammatory proteins and upregulate the cAMP/PKA pathway, which suppressing inflammation and improving insulin sensitivity, significantly regulating type I and type II diabetes [13,14]. The gene discussed is NFKB1; the disease is type 2 diabetes mellitus.